<?xml version='1.0' encoding='utf-8'?>
<document id="27595796"><sentence text="An exposure-response analysis based on rifampin suggests CYP3A4 induction is driven by AUC: an in vitro investigation."><entity charOffset="39-47" id="DDI-PubMed.27595796.s1.e0" text="rifampin" /></sentence><sentence text="1" /><sentence text=" Induction is an important mechanism contributing to drug-drug interactions" /><sentence text=" It is most commonly evaluated in the human hepatocyte assay over 48-h or 72-h incubation period" /><sentence text=" However, whether the overall exposure (i" /><sentence text="e" /><sentence text=" Area Under the Curve (AUC) or Cave) or maximum exposure (i" /><sentence text="e" /><sentence text=" Cmax) of the inducer is responsible for the magnitude of subsequent induction has not been thoroughly investigated" /><sentence text=" Additionally, in vitro induction assays are typically treated as static systems, which could lead to inaccurate induction potency estimation" /><sentence text=" Hence, European Medicines Agency (EMA) guidance now specifies quantitation of drug levels in the incubation" /><sentence text=" 2" /><sentence text=" This work treated the typical in vitro evaluation of rifampin induction as an in vivo system by generating various target engagement profiles, measuring free rifampin concentration over 3 d of incubation and evaluating the impact of these factors on final induction response"><entity charOffset="54-62" id="DDI-PubMed.27595796.s13.e0" text="rifampin" /><entity charOffset="159-167" id="DDI-PubMed.27595796.s13.e1" text="rifampin" /><pair ddi="false" e1="DDI-PubMed.27595796.s13.e0" e2="DDI-PubMed.27595796.s13.e0" /><pair ddi="false" e1="DDI-PubMed.27595796.s13.e0" e2="DDI-PubMed.27595796.s13.e1" /></sentence><sentence text=" 3" /><sentence text=" This rifampin-based analysis demonstrates that the induction process is driven by time-averaged target engagement (i"><entity charOffset="6-14" id="DDI-PubMed.27595796.s15.e0" text="rifampin" /></sentence><sentence text="e" /><sentence text=" AUC-driven)" /><sentence text=" Additionally, depletion of rifampin in the incubation medium over 3 d as well as non-specific/specific binding were observed"><entity charOffset="28-36" id="DDI-PubMed.27595796.s18.e0" text="rifampin" /></sentence><sentence text=" 4" /><sentence text=" These findings should help aid the discovery of clinical candidates with minimal induction liability and further expand our knowledge in the quantitative translatability of in vitro induction assays" /><sentence text="" /></document>